Skip to main content
. 2018 Jan 29;41(2):119–126. doi: 10.14348/molcells.2018.2235

Fig. 1. Downregulation of miR-612 predicts poor prognosis in melanoma patients (n = 89).

Fig. 1

(A) qRT-PCR analysis of miR-612 levels in 89 pairs of melanoma tissues and adjacent normal tissues. (B) Kaplan-Meier analysis of the correlation between miR-612 expression and melanoma patient survival. Significance was determined by the log-rank test.